Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Index funds provide broad diversification, low costs, and simple investment. They’re a solid foundation for long-term growth and reduced risk.
17,715 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Kraft Heinz reports solid free cash flow while store-brand competition erodes volumes, prompting a pivot away from a ...
Animoca Brands announces a strategic investment in the AVAX token and a partnership with Ava Labs to accelerate Avala...
Craig Newmark is pledging to donate the bulk of his fortune, about $450 million, to issues such as misinformation and...
Dell Technologies stock just moved on headlines about a rival's legal trouble, but the bigger question for investors ...
Looking for a simple, durable path to cash flow and growth? This article breaks down three reliable dividend stocks h...
Billionaire donors are steering college hoops beyond winnings, fueling facilities, NIL deals, and recruiting as the S...
Target’s dividend king status remains intact for now, but a cash flow squeeze and higher capex raise questions for in...
A new Allianz study shows Gen X is the cohort most worried about taxes in retirement, with rising fears about how tax...
Oil hovers around $100 a barrel on March 25, 2026, as traders weigh demand growth against supply risks. The piece exp...
Circle Internet Group stock has tumbled amid regulatory whispers around stablecoins. This guide breaks down what the ...
Rockwell Medical is a niche player in renal care. This analysis breaks down rockwell medical (rmti) earnings, what th...